Several metrics are used to measure the efficacy of cancer treatments:
Overall Survival (OS): The length of time from diagnosis or start of treatment that patients are still alive. Progression-Free Survival (PFS): The length of time during and after treatment that a patient lives with the disease but it does not get worse. Objective Response Rate (ORR): The proportion of patients whose cancer shrinks or disappears after treatment. Quality of Life (QoL): Assessment of patients' overall well-being, including physical, emotional, and social aspects, during and after treatment.